Atheln, Inc.

Atheln helps clients create and execute integrated pharma and biotech product development and commercialization strategies. Our approach is unique in its integration of commercial and technical disciplines to maximize product value, relentless focus on identifying the key disciplines addressing client needs, exclusively utilizing industry seasoned experts, and being solely driven by client success. This approach is rooted in our extensive hands-on experience spanning from early research to life cycle management. Our global team of over 100 highly specialized, industry-seasoned experts excel at risk identification and mitigation, while delivering phase appropriate and customized solutions that increase value and likelihood of success. Each of our experts located in the US and EU have 20 - 40 years of global strategic and operational experience in Fortune 500 and start-up companies. Specialized teams are created for each project to address the specific needs of the client for single and/or multi-competency projects, interim, long-term or project based needs. In thirteen years, Atheln has built up a top notch consulting practice and worked with over 120 companies in the US, Canada, Europe and Asia. Type of Products Biologics (recombinant, fusion and transgenic proteins, MAbs, vaccines, biosimilars, ADCs, cell and gene therapies), small molecules, combination products, medical devices. Therapeutic Areas Addiction, aesthetics, autoimmune disease, dermatology, endocrinology, gastroenterology, hematology, infectious diseases, immunology, nephrology, neurodegenerative diseases, neurology, oncology, ophthalmology, pain, psychiatry, rare diseases, transplantation, and urology